India has over 10 crore people living with diabetes — the highest absolute number of any country in the world. Most discussions about diabetes complications focus on blood sugar control, heart disease, and kidney damage. But a quieter epidemic runs alongside these: diabetic neuropathy, a progressive nerve disease that causes burning feet, painful tingling, and numbness that eventually steals the ability to feel an injury. Studies estimate that between 28% and 78% of Indian diabetics have some degree of peripheral neuropathy — yet the condition is routinely underdiagnosed and undertreated, often dismissed as "normal ageing" or chronic fatigue.
This guide explains what diabetic neuropathy is, how it is diagnosed in Indian clinics, what tests to ask for, and how it is treated — including the Indian brand names of medicines your doctor may prescribe.
What is Diabetic Neuropathy?
Diabetic neuropathy is nerve damage caused by chronically high blood sugar. Over time, elevated glucose levels damage the walls of the tiny blood vessels (called capillaries) that supply oxygen and nutrients to the nerves. Without a steady blood supply, nerves begin to malfunction and eventually die — and unlike most cells in the body, nerve cells have very limited capacity to regenerate.
The condition most commonly affects the peripheral nerves — those outside the brain and spinal cord — which explains why the feet, legs, and hands are affected first and most severely. Because the longest nerves in the body run to the feet, they are the earliest casualties.
Types of Diabetic Neuropathy
Diabetic neuropathy is not one condition but a family of nerve disorders. Understanding the type helps explain symptoms that might otherwise seem unrelated:
Peripheral Neuropathy (Diabetic Peripheral Neuropathy / DPN) The most common type, affecting roughly 50% of all long-term diabetics. It damages the sensory and motor nerves of the feet, legs, and sometimes hands, causing the classic burning-tingling-numbness pattern. This is the primary focus of this guide.
Autonomic Neuropathy Affects the nerves that control automatic body functions — heart rate, blood pressure, digestion, bladder control, and sweating. Manifestations include gastroparesis (slow stomach emptying, causing nausea and erratic blood sugar levels), bladder dysfunction, orthostatic hypotension (dizziness on standing), and reduced ability to recognise hypoglycaemia.
Proximal Neuropathy (Diabetic Amyotrophy) A less common but painful condition affecting the thighs, hips, and buttocks, causing sudden severe pain and muscle weakness on one side of the body.
Focal Neuropathy (Mononeuropathy) Sudden damage to a single specific nerve — most commonly causing facial palsy (Bell's palsy-like presentation), carpal tunnel syndrome, or double vision from damage to cranial nerves.
How Common is Diabetic Neuropathy in India?
The burden in India is substantial and growing:
- Studies from Indian hospitals estimate DPN prevalence between 28% and 78% in type 2 diabetics, depending on the population studied and diagnostic method used
- A 2024 multi-centre study found 31.1% prevalence in a rural South Indian diabetic population — meaning nearly 1 in 3 diabetics had neuropathy
- Poor glycaemic control (high HbA1c), longer duration of diabetes, and concurrent hypertension are the strongest risk factors in Indian cohorts
- DPN is significantly more common in patients who have had diabetes for more than 5–10 years and those with HbA1c above 8%
- India's high rates of undiagnosed and uncontrolled diabetes make the true neuropathy burden likely far higher than reported numbers suggest
Symptoms: Recognising Diabetic Neuropathy
The symptoms of diabetic peripheral neuropathy can be subtle at first and are often blamed on other causes — fatigue, bad footwear, or "growing older." Knowing the pattern matters.
Early Symptoms
- Tingling or "pins and needles" in the feet and toes — often the first symptom; worse at night
- Burning sensation in the feet — described as walking on hot sand, even in cool weather; a particularly common complaint among Indian patients
- Numbness — a gradual loss of sensation beginning at the toes and progressing upward (called the "glove and stocking" distribution)
- Increased sensitivity — light touch or the pressure of a bedsheet feels painful (allodynia)
- Calluses forming on the feet without the patient noticing, due to reduced protective sensation
Later Symptoms
- Complete loss of protective sensation in the feet — patients cannot feel a cut, blister, or burn
- Muscle weakness in the feet and ankles, causing a change in gait
- Loss of balance — particularly at night or in dark rooms, when visual compensation for poor proprioception is reduced
- Foot deformities — hammer toes and Charcot foot (a severe collapse of the foot bones) in advanced cases
The Danger Zone: Diabetic Foot
The most feared consequence of diabetic neuropathy is the diabetic foot — a foot that cannot feel injury. A small cut from a stone, a blister from a new pair of chappals, or a toenail grown into the skin can become a deep infection without any pain warning. In India, diabetic foot complications are the most common cause of non-traumatic lower limb amputation. Studies suggest India performs over 75,000 diabetes-related amputations annually — the majority preventable with regular foot examination and protective footwear.
Diagnosis: Tests for Diabetic Neuropathy in India
Diabetic neuropathy is both a clinical diagnosis (based on symptoms and physical examination) and a confirmed diagnosis using specific tests. Ask your diabetologist or general physician about the following.
1. Monofilament Test (10g Semmes-Weinstein Monofilament)
A simple, inexpensive bedside test using a thin plastic filament pressed against several points on the foot. If the patient cannot feel the pressure, it indicates loss of protective sensation. Every diabetic should have this done at least annually — it takes two minutes and costs nothing. Despite its proven effectiveness, studies show it is performed in fewer than 20% of Indian diabetic clinic visits.
What the result means:
- Feels the filament at all test points → normal sensation
- Cannot feel at 1–2 points → borderline, monitor closely
- Cannot feel at 3+ points → significant loss of protective sensation; immediate foot care advice needed
2. Biothesiometry (Vibration Perception Threshold / VPT)
A biothesiometer is a handheld device that delivers calibrated vibrations to the big toe or heel. The lowest level of vibration the patient can feel is recorded — called the Vibration Perception Threshold (VPT).
| VPT Reading | Interpretation |
|---|---|
| < 15 volts | Normal |
| 15–25 volts | Mild neuropathy; monitor |
| 25–40 volts | Moderate neuropathy; active management needed |
| > 40 volts | Severe neuropathy; high foot ulcer risk |
Biothesiometry has higher sensitivity than monofilament testing for detecting early DPN, according to Indian studies comparing it against NCS (see below). Most large hospitals and diabetology clinics in India have biothesiometers.
Approximate cost: ₹300–₹800 at most tertiary care centres and diabetology clinics.
3. Nerve Conduction Study (NCS / NCV)
The gold standard for diagnosing and grading peripheral neuropathy. NCS measures how fast electrical signals travel through specific nerves (motor and sensory) and the amplitude of those signals.
In DPN, NCS typically shows:
- Reduced nerve conduction velocity (NCV) — signals travel more slowly
- Reduced amplitude of sensory nerve action potentials, particularly in the sural nerve (a purely sensory nerve in the leg)
- In more advanced disease, motor nerve involvement in the peroneal and tibial nerves
NCS is performed by a neurologist and involves placing electrode patches on the skin and delivering small electrical pulses — mildly uncomfortable but not painful. It takes 30–60 minutes.
Approximate cost in India: ₹1,500–₹4,000 at private neurophysiology labs; ₹200–₹800 at government hospitals.
4. Electromyography (EMG)
Often done alongside NCS, EMG tests the electrical activity within muscles — particularly useful when motor neuropathy or weakness is present. Less commonly needed for straightforward DPN assessment.
5. Quantitative Sensory Testing (QST)
Measures temperature and vibration sensitivity through standardised computer-controlled protocols. Less widely available in India but offered at large academic centres. Useful for early small-fibre neuropathy, which NCS can miss.
6. Skin Punch Biopsy (Intraepidermal Nerve Fibre Density / IENF)
A highly specialised test — a small skin biopsy is stained to count the density of nerve fibres in the outer skin layer. Used in research and for diagnosing small-fibre neuropathy, where conventional NCS is normal despite significant symptoms. Available only at major academic hospitals (AIIMS, CMC Vellore, PGIMER Chandigarh, Apollo). Cost: ₹5,000–₹12,000.
Recommended Minimum Testing for Most Indian Patients
For a typical diabetic patient in India, the practical diagnostic approach recommended at a district hospital or diabetology clinic is:
- Annual monofilament test at every diabetology visit
- Biothesiometry when monofilament shows borderline or abnormal results
- NCS/NCV when the diagnosis is uncertain, symptoms are atypical, or severity needs to be graded for treatment planning
Treatment: Managing Diabetic Neuropathy
There is no treatment that reverses established diabetic neuropathy — but there is substantial evidence that it can be slowed, stabilised, and its painful symptoms significantly reduced.
The Foundation: Tight Glycaemic Control
The single most important intervention is achieving and maintaining good blood sugar control. Evidence from the DCCT trial (type 1 diabetes) and UKPDS (type 2) demonstrated that intensive glucose lowering significantly reduces the risk of developing DPN and slows its progression.
- Target HbA1c: < 7% (or 53 mmol/mol) for most patients with established DPN, in consultation with your diabetologist
- SMBG (self-monitoring of blood glucose): Important for catching post-meal spikes that damage nerve capillaries
- Avoiding hypoglycaemia: Paradoxically, severe repeated hypoglycaemia also damages nerves — so insulin intensification requires careful monitoring
Blood Pressure and Lipid Control
Hypertension and dyslipidaemia independently worsen nerve blood supply. Indian guidelines recommend:
- Blood pressure target: < 130/80 mmHg in diabetics with neuropathy
- ACE inhibitors or ARBs as preferred antihypertensives (additional protective effect on nerves)
- Statin therapy if LDL-cholesterol is elevated
Medications for Neuropathic Pain
Pain is the most debilitating feature of DPN for many patients. These are the medications commonly prescribed in India, with Indian brand names.
1. Pregabalin (First-line) A GABA analogue that reduces the hyperexcitability of damaged nerves. Recommended as first-line therapy for painful DPN by most international guidelines.
- Dose: 75–300 mg per day, divided doses
- Common Indian brands: Lyrica (Pfizer), Pregalin (Sun Pharma), Pregabalin (various generics from ₹50–₹180/10 tablets)
- Side effects: Dizziness, drowsiness, weight gain, ankle swelling — usually manageable at lower doses
- Note: Schedule H drug; requires prescription; potential for dependence with long-term use
2. Duloxetine (First-line) A serotonin-norepinephrine reuptake inhibitor (SNRI) with established efficacy in painful DPN. FDA-approved specifically for this indication.
- Dose: 60–120 mg per day (start at 30 mg for 1–2 weeks)
- Common Indian brands: Duzela (Cipla), Cymbalta (Eli Lilly), Dulane (Sun Pharma), Duloxetine generics (₹100–₹300/30 tablets)
- Side effects: Nausea (usually transient), insomnia, dry mouth, appetite loss
- Comparison with pregabalin: An Indian study found duloxetine had slightly better pain reduction but more side effects than pregabalin; both are effective; the choice depends on individual tolerability
3. Gabapentin (Second-line) Similar to pregabalin but generally considered less potent. Often used as a cost-effective alternative.
- Dose: 300–1800 mg/day in divided doses
- Common Indian brands: Gabantin (Sun Pharma), Neurontin (Pfizer), Gabatop (Micro Labs), generics from ₹20–₹60/10 tablets
- Side effects: Similar to pregabalin — dizziness, fatigue, weight gain
4. Amitriptyline (Second-line) A tricyclic antidepressant that has been used for neuropathic pain for decades. Very cost-effective but has more side effects, particularly in elderly patients (dry mouth, constipation, cardiac effects).
- Dose: 10–75 mg at bedtime
- Common Indian brands: Amitone (Pfizer), Tryptomer (Cipla), generics (₹10–₹30/10 tablets — extremely affordable)
- Best suited for: Younger patients without cardiac conditions, particularly where cost is a primary concern
5. Tramadol (for severe breakthrough pain) An opioid-class analgesic sometimes used for refractory severe neuropathic pain unresponsive to first and second-line agents. Short-term use only; significant addiction potential. Not recommended as primary therapy.
6. Topical Capsaicin (Adjunctive) A cream derived from chilli peppers that depletes Substance P, a pain neurotransmitter, from local nerve endings. Available over the counter in India.
- Common Indian brands: Capsigel (₹120–₹150 for 30g tube)
- Use: Best for localised painful areas; ineffective for widespread neuropathy
- Caveat: Can cause intense burning sensation on first few applications
Vitamins and Supplements: What the Evidence Shows
Many Indian patients are prescribed or self-purchase B-complex vitamins and alpha-lipoic acid for neuropathy. Here is what the evidence actually supports:
Methylcobalamin (Vitamin B12): B12 deficiency — extremely common in Indian vegetarians and in diabetics taking metformin (which reduces B12 absorption) — directly causes neuropathy indistinguishable from DPN. All diabetics on metformin should have annual B12 testing and supplement if levels are low. B12 supplementation does not improve established DPN in patients with normal B12 levels but is essential if deficiency is present.
Alpha-Lipoic Acid: An antioxidant with the most evidence among supplements for diabetic neuropathy — European trials (ALADIN, SYDNEY) showed modest improvement in neuropathic symptoms with 600 mg IV or oral doses. Used extensively in Germany and some Indian diabetology practices. Available in India as Thioctacid (Wockhardt), ALA supplements (₹200–₹400/30 capsules). Evidence is moderate, not definitive; effect size is smaller than first-line drugs.
B-Complex (B1, B6, B12): Widely prescribed in India (Becosules, Neurobion); evidence for effect on established DPN is limited unless a specific B12 deficiency is corrected. Not harmful at standard doses.
Physical Therapy and Lifestyle
Physical interventions have modest but real benefit:
- Foot care exercises: Specific toe-flexion and ankle-rotation exercises improve circulation in the feet
- Balance training and proprioception exercises: Reduce fall risk in patients with significant proprioceptive loss
- TENS (Transcutaneous Electrical Nerve Stimulation): Modest pain relief for some patients; widely available at physiotherapy clinics (₹200–₹400/session in India)
- Walking and aerobic exercise: Directly improves peripheral nerve function through enhanced blood flow — 30 minutes of walking 5 days a week has been shown in trials to improve nerve conduction velocity
Foot Care: The Most Important Prevention Strategy
For patients who already have significant sensory loss, daily foot care is non-negotiable. The goal is to prevent the minor injuries that diabetic feet cannot feel — and that can progress to infections, ulcers, and amputation.
Daily foot care routine:
- Inspect your feet every day — top, bottom, between toes — ideally with a mirror or with help from a family member
- Wash feet in lukewarm water (never hot — you cannot feel a burn); dry completely, especially between toes
- Moisturise the heels and soles (not between the toes) to prevent cracking
- Cut toenails straight across — never curved; file sharp edges
- Never walk barefoot — indoors or outdoors; always wear protective footwear
- Wear well-fitting cotton socks — no tight elastic bands
- Inspect the inside of footwear before wearing for stones, seams, or foreign objects
- Never use heating pads, hot water bottles, or open fire to warm numb feet
See your doctor immediately if you notice:
- A blister, cut, bruise, or sore on the foot, no matter how small
- Redness, swelling, or warmth in any part of the foot
- Any change in the colour of the foot or toes (dark patches, blue/black discolouration)
- A foot wound that is not healing within 2–3 days
The "Triopathy" Connection
Diabetic peripheral neuropathy, diabetic retinopathy (eye damage), and diabetic nephropathy (kidney damage) are collectively called the "diabetic triopathy" — three complications that share the same underlying mechanism (microvascular damage from hyperglycaemia) and often occur together. If a patient has significant DPN, their doctor should also screen for:
- Annual fundus examination for retinopathy (see our diabetic retinopathy guide)
- Annual urine microalbumin and creatinine/KFT for nephropathy (see our kidney function test guide)
- Regular ECG and cardiac assessment, as autonomic neuropathy can cause silent myocardial infarction
Controlling glucose aggressively benefits all three complications simultaneously.
Tracking Your Neuropathy Over Time
Because neuropathy progresses slowly, tracking tests over time is more informative than any single result. You can store your NCS reports, biothesiometry results, and HbA1c tests in MedicalVault, and our trend analysis feature lets you visualise how test values are changing across visits.
If you are managing a parent or family member's diabetes-related complications, the family sharing feature allows you to access their reports remotely and share summaries with different specialists. This is particularly useful when coordinating care between a diabetologist, neurologist, and foot care specialist.
For more on monitoring blood sugar control, see our guides on HbA1c testing and fasting and PP blood sugar tests.
Key Takeaways
- Diabetic peripheral neuropathy affects 28–78% of Indian diabetics and is severely under-detected; the main early symptoms are burning feet, tingling, and numbness starting in the toes
- The "glove and stocking" pattern of sensory loss — progressing from toes upward — is the hallmark; severe cases lose protective sensation entirely and are at high risk of foot ulcers and amputation
- Annual monofilament testing is the minimum standard of care and takes two minutes; biothesiometry and NCS are available at most large centres for more thorough assessment
- Tight glycaemic control (HbA1c < 7%) is the only treatment that slows progression — pain medications treat symptoms but do not address the underlying nerve damage
- First-line pain medications in India: pregabalin (Lyrica/Pregalin) and duloxetine (Duzela/Dulane) — both effective, with some differences in tolerability and cost
- Diabetics on metformin should test B12 annually — B12 deficiency from metformin is a common, treatable cause of worsening neuropathy
- Daily foot inspection and protective footwear are the most important strategies for preventing diabetic foot complications
- Consult your diabetologist or neurologist before starting or changing any medication; neuropathy treatment requires personalised assessment